Real World Experience With Vivity Edof Iol In Cataract Patients With Concurrent Eye Pathology Or Post Refractive Surgery Patients
Published 2023 - 41st Congress of the ESCRS
Reference: PO0524 | Type: Free paper | DOI: 10.82333/0h6c-ty48
Authors: Wong Jun Shyan* 1 , Shin Ying Tang 2
1International Specialist Eye Centre (ISEC) ,Kuala Lumpur,Malaysia, 2ISEC,Kuala Lumpur,Malaysia
Purpose
Extended depth of focus (EDOF) intraocular lens (IOL) are designed to provide a high degree of spectacle independence in cataract surgery patients with less visual side effects as compared to refractive/diffractive multifocal (MF) IOL. In patient with less than ideal situation, ie with concurrent mild ocular pathology or post refractive surgery patients, multifocal IOL implant may not be suitable, and EDOF lenses may be a better option. We seek to find out how the real world visual performance and satisfaction outcomes of a new EDIOF IOL (Alcon Vivity/Vivity Toric) in a clinic population who were deemed not suitable for MF IOL.
Setting
Retrospective, single-centre, single-surgeon,nonrandomised, noncomparative case series.
Methods
Vision parameters analysed included preoperative unaided vision, postoperative vision (distance, intermediate and near) at month one, target refraction status, and questionnaires regarding incidence of side effects (glare/haloes) and functional satisfaction such as dependency on glasses post-surgery. We also analyse by subgroup the performance of these EDOF lenses. 116 eyes in 83 consecutive patients were analysed.
Results
There was significant improvement in preoperative vs postoperative unaided vision at all distances. Mean unaided distance visual acuity pre-operation improved from 6/15 to 6/9.5 at month one. 48 percent and 70 percent of patients reported satisfaction with near and intermediate vision respectively. Patient vision satisfaction and functional ability is generally favourable.
Conclusions
Alcon Vivity EDOF IOL gives acceptable unaided near, and excellent intermediate and far vision at month one post surgery, and high degree of spectacles independence in cataract patients deemed not suitable for MF IOL with minimal side effects.